AskBio brings on new president of therapeutics

AskBio has tapped Dr. Katherine High as president of therapeutics, a new role in which she will lead the company’s preclinical and clinical programs for adeno-associated virus (AAV) gene therapy. Previously, High was president and head of research and development at Spark Therapeutics.

Amylyx Pharmaceuticals snares former Alkermes CFO

Amylyx Pharmaceuticals announced James Frates will join the company as chief financial officer. Frates, a cousin of ALS activist Pete Frates, previously spent 22 years at Alkermes.

Finn Partners announces new partner

Finn Partners has added Susan Drew to its New York health practice leadership team. Drew arrives from Chandler Chicco Agency, where she led agency accounts on medical devices and rare diseases.

Healthline Media hires new editor-in-chief

Healthline Media has brought in Faye McCray as editor in chief of, a site covering psychology and mental health issues. McCray previously served as editor in chief at Tax Notes.

Able Channel appoints NASA astronaut to Board of Directors

Dr. Bernard Harris, a doctor and NASA astronaut, has been appointed to the Able Channel’s board of directors. Harris is the founder of the Harris Institute and Foundation and a founder and managing partner of Vesalius Ventures, which invests in healthcare technologies.

Nucleus Global taps Dan Bridges as CEO

Specialist medical communications network Nucleus Global announced it has promoted Dan Bridges to CEO. Bridges was previously the company’s Europe regional director.

LaVoieHealthScience hires two, promotes two

LaVoieHealthScience has added Barrett McGrath as senior business development advisor and Elizabeth Aguiló as talent acquisition consultant. It promoted Lisa DeScenza to VP, integrated communications and head, business development and marketing and Sharon Choe to SVP and head, outreach and corporate access.